1. Home
  2. ACFN vs CELU Comparison

ACFN vs CELU Comparison

Compare ACFN & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACFN
  • CELU
  • Stock Information
  • Founded
  • ACFN 1986
  • CELU 2016
  • Country
  • ACFN United States
  • CELU United States
  • Employees
  • ACFN N/A
  • CELU N/A
  • Industry
  • ACFN Military/Government/Technical
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACFN Consumer Discretionary
  • CELU Health Care
  • Exchange
  • ACFN Nasdaq
  • CELU Nasdaq
  • Market Cap
  • ACFN 76.5M
  • CELU 64.3M
  • IPO Year
  • ACFN N/A
  • CELU N/A
  • Fundamental
  • Price
  • ACFN $29.77
  • CELU $2.32
  • Analyst Decision
  • ACFN
  • CELU Strong Buy
  • Analyst Count
  • ACFN 0
  • CELU 1
  • Target Price
  • ACFN N/A
  • CELU $6.00
  • AVG Volume (30 Days)
  • ACFN 25.8K
  • CELU 133.2K
  • Earning Date
  • ACFN 11-06-2025
  • CELU 08-29-2025
  • Dividend Yield
  • ACFN N/A
  • CELU N/A
  • EPS Growth
  • ACFN 1520.82
  • CELU N/A
  • EPS
  • ACFN 2.84
  • CELU N/A
  • Revenue
  • ACFN $13,202,000.00
  • CELU $44,590,000.00
  • Revenue This Year
  • ACFN N/A
  • CELU $23.29
  • Revenue Next Year
  • ACFN N/A
  • CELU N/A
  • P/E Ratio
  • ACFN $10.50
  • CELU N/A
  • Revenue Growth
  • ACFN 50.98
  • CELU 4.45
  • 52 Week Low
  • ACFN $17.22
  • CELU $1.00
  • 52 Week High
  • ACFN $33.00
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • ACFN N/A
  • CELU 37.21
  • Support Level
  • ACFN N/A
  • CELU $2.02
  • Resistance Level
  • ACFN N/A
  • CELU $2.53
  • Average True Range (ATR)
  • ACFN 0.00
  • CELU 0.30
  • MACD
  • ACFN 0.00
  • CELU -0.14
  • Stochastic Oscillator
  • ACFN 0.00
  • CELU 15.08

About ACFN Acorn Energy Inc. Common Stock

Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: